Pineda, Miguel ACuervo, HenarFresno, ManuelSoto, ManuelBonay, Pedro2024-01-172024-01-172015-10-01J Infect Dis. 2015 Oct 1;212(7):1160-71.http://hdl.handle.net/20.500.12105/17216BACKGROUND Chagas disease is caused by the protozoan Trypanosoma cruzi, affecting millions of people worldwide. One of the major causes of mortality in the disease is the cardiomyopathy observed in chronic patients, despite the low number of parasites detected in cardiac tissue. Galectin-3, a carbohydrate-binding protein with affinity for β-galactoside-containing glycoconjugates, is upregulated upon infection, and it has been recently involved in the pathophysiology of heart failure. METHODS We investigated the role of galectin-3 in systemic and local responses in a murine model of T. cruzi infection, using knockout animals. Molecular mechanisms underlying galectin-3-dependent inflammatory responses were further assessed in cultured dendritic cells in vitro. RESULTS Mice deficient for galectin-3 have elevated blood parasitemia levels and impaired cytokine production during infection. Remarkably, galectin-3 promotes cellular infiltration in the heart of infected mice and subsequent collagen deposition and cardiac fibrosis. Furthermore, we show that an unbalanced Toll-like receptor expression on antigen-presenting cells may be the cause of the impaired immune response observed in galectin-3-deficient mice in vivo. CONCLUSIONS These results suggest that galectin-3 is strongly involved in Chagas disease, not only in the immune response against T. cruzi, but also in mediating cardiac tissue damage.engVoRAnimalsAntigen-Presenting CellsChagas CardiomyopathyChagas DiseaseChlorocebus aethiopsFibrosisGalactosidesGalectin 3HumansImmunity, InnateMiceMice, KnockoutMyocardiumParasitemiaReceptors, Cell SurfaceToll-Like ReceptorsTrypanosoma cruziVero CellsAttribution-NonCommercial-NoDerivatives 4.0 Internacional258057532127116010.1093/infdis/jiv1851537-6613The Journal of infectious diseasesopen access